Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126536461 | 12653646 | 1 | I | 2015 | 20160608 | 20160815 | 20160815 | PER | US-ASTRAZENECA-2016SE62456 | ASTRAZENECA | 75.00 | YR | F | Y | 77.10000 | KG | 20160816 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126536461 | 12653646 | 1 | PS | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 19962 | 50 | MG | MODIFIED-RELEASE TABLET | QD | |||||||
126536461 | 12653646 | 2 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | 20639 | 25 | MG | TABLET | QD | |||||||
126536461 | 12653646 | 3 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | UNK | 0 | 20 | MG | CAPSULE | QD | ||||||
126536461 | 12653646 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 0 | 100 | MG | TABLET | QD | |||||||
126536461 | 12653646 | 5 | SS | LYRICA | PREGABALIN | 1 | Oral | 100MG CAPSULE ONE IN MORNING AND ONE IN EVENING | 0 | CAPSULE | |||||||||
126536461 | 12653646 | 6 | SS | UNSPECIFIED DRUG | UNSPECIFIED INGREDIENT | 1 | Oral | 25MG TABLET ONE IN MORNING AND ONE IN EVENING | 0 | TABLET | |||||||||
126536461 | 12653646 | 7 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 0 | 25 | MG | TABLET | BID | |||||||
126536461 | 12653646 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | 40 | MG | QD | |||||||||
126536461 | 12653646 | 9 | C | MECLIZINE HCL | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
126536461 | 12653646 | 10 | C | LACTULOSE. | LACTULOSE | 1 | 0 | ||||||||||||
126536461 | 12653646 | 11 | C | LANCTUS | 2 | 0 | |||||||||||||
126536461 | 12653646 | 12 | C | HUMALOG | INSULIN LISPRO | 1 | 0 | ||||||||||||
126536461 | 12653646 | 13 | C | BYETTA | EXENATIDE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126536461 | 12653646 | 2 | Sleep disorder |
126536461 | 12653646 | 4 | Neuralgia |
126536461 | 12653646 | 5 | Pain in extremity |
126536461 | 12653646 | 6 | Neuralgia |
126536461 | 12653646 | 7 | Liver disorder |
126536461 | 12653646 | 8 | Diuretic therapy |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126536461 | 12653646 | Amnesia | |
126536461 | 12653646 | Drug administration error | |
126536461 | 12653646 | Mental disorder | |
126536461 | 12653646 | Off label use | |
126536461 | 12653646 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126536461 | 12653646 | 2 | 2015 | 0 | ||
126536461 | 12653646 | 3 | 2015 | 0 | ||
126536461 | 12653646 | 4 | 2015 | 0 | ||
126536461 | 12653646 | 6 | 2015 | 0 | ||
126536461 | 12653646 | 7 | 2015 | 0 |